- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Solid Tumors in Japan
Total 518 results
-
Yosuke UchitomiRecruitingAdvanced Cancer | Recurrent Cancer | End of Life CareJapan
-
National Cancer Center Hospital EastMerck Sharp & Dohme LLC; Eisai Co., Ltd.CompletedAdvanced Gastric CancerJapan
-
Zeria PharmaceuticalCompletedAdvanced Hepatocellular CarcinomaJapan
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer | Solid Tumors | Programmed Cell Death-1 (PD1, PD-1) | Programmed Cell Death 1 Ligand 1(PDL1, PD-L1) | Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)Japan
-
Incyte CorporationRecruitingSolid TumorsUnited States, Japan, France, Italy, United Kingdom, Netherlands, Switzerland
-
Novartis PharmaceuticalsTerminatedSolid Tumors and LymphomasUnited States, Australia, Netherlands, Canada, Germany, Switzerland, Japan, Spain
-
Cancer Intelligence Care Systems, Inc.Stella Pharma CorporationCompletedAngiosarcoma | Malignant MelanomaJapan
-
Chiba UniversityUnknownPancreatic Tumor | Bile Duct TumorJapan
-
Novartis PharmaceuticalsEckert & Ziegler Radiopharma GmbHRecruiting
-
Daiichi SankyoDaiichi Sankyo, Inc.Active, not recruiting
-
AstraZenecaMedImmune LLCCompletedBlood Cancer | Advanced B Cell MalignanciesJapan
-
Incyte CorporationTerminatedAdvanced MalignanciesUnited States, Italy, Denmark, Japan
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerJapan
-
Kyushu UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
AO Innovation Translation CenterAO Foundation, AO SpineRecruitingMetastatic Spine TumorUnited States, Canada, Hungary, Australia, Germany, Italy, Japan, Netherlands, Singapore, Switzerland
-
Mie UniversityCompleted
-
Merck Sharp & Dohme LLCRecruitingSolid Tumors | Hematologic MalignanciesUnited States, Poland, Brazil, Ukraine, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic... and more
-
Taiho Oncology, Inc.CompletedBreast Cancer | Gastric Cancer | Cholangiocarcinoma | Urothelial Cancer | Primary CNS Tumors | Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR TumorsFrance, United States, Korea, Republic of, United Kingdom, Japan, Hong Kong, Australia, Taiwan, Italy, Canada, Germany, Netherlands, Spain
-
Kyowa Kirin Co., Ltd.Completed
-
Novartis PharmaceuticalsActive, not recruitingSomatostatin Receptor-positive Neuroendocrine TumorJapan
-
AmgenTerminatedMUC17-positive Solid TumorsUnited States, Korea, Republic of, Taiwan, Spain, Austria, France, Japan, Germany, Netherlands
-
PfizerCompletedPancreatic Neuroendocrine TumorsJapan
-
Novartis PharmaceuticalsRecruitingMelanoma | Solid Tumor | High Grade Glioma | Non Small Cell Lung Cancer | Rare CancersSpain, Germany, United States, Argentina, Austria, Denmark, France, Hungary, Netherlands, China, Japan, Thailand
-
Novartis PharmaceuticalsRecruitingAdvanced EGFRmutant NonSmallSellLungCancer (NSCLC),KRAS G12-mutant NSCLC,Esophageal SquamousCellCancer (SCC),Head/Neck SCC,MelanomaNetherlands, Korea, Republic of, Spain, Taiwan, Japan, Italy, United States, Singapore, Canada
-
AstraZenecaCompleted
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingAdvanced or Metastatic Renal Cell CarcinomaJapan
-
AstraZenecaCompletedPart A and B: Advanced Solid Malignancies | Part C: Malignant MesotheliomaJapan
-
Eisai Co., Ltd.CompletedMalignant GliomaJapan
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
Eisai Co., Ltd.Completed
-
HutchmedActive, not recruitingNeuroendocrine Tumors | Non-hematologic MalignancyJapan
-
BayerActive, not recruitingSolid Tumors Harboring NTRK FusionUnited States, Korea, Republic of, China, Japan, India, France, Turkey, Portugal, Spain, Taiwan, Czechia, Sweden, Brazil, Denmark, Singapore, Argentina, Germany, Ireland
-
NobelpharmaCompleted
-
Novartis PharmaceuticalsCompletedGastrointestinal Stromal TumorsJapan
-
Kyowa Kirin Co., Ltd.CompletedAdvanced/Recurrent Non-small-cell Lung CancerJapan
-
University of Texas Southwestern Medical CenterWithdrawnLocally Advanced Pancreatic AdenocarcinomaUnited States, Japan
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingSolid TumorsKorea, Republic of, United States, Spain, United Kingdom, Russian Federation, Argentina, Australia, Italy, Japan, Belgium, Brazil, Czechia, France, Germany, Hungary, Romania, Turkey, Bulgaria, Mexico, Poland, Thailand, Ukraine
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerCanada, Korea, Republic of, Taiwan, United States, Italy, United Kingdom, Thailand, Russian Federation, India, Belgium, Australia, Poland, Spain, Japan, Brazil, Czechia, Netherlands
-
BayerCompleted
-
Eisai Co., Ltd.Ono Pharmaceutical Co. LtdActive, not recruiting
-
AstraZenecaCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of, China, Japan
-
Kobe City General HospitalTerminatedAdvanced Non-small Cell Lung CancerJapan
-
National Cancer Center, JapanOno Pharmaceutical Co. Ltd; Fiverings Co., Ltd.Active, not recruitingLocally Advanced Esophageal Squamous Cell CarcinomaJapan
-
AstraZenecaTerminatedInoperable Locally Advanced or Metastatic Biliary Tract CancerJapan
-
National Cancer Center, JapanMerck Sharp & Dohme LLCRecruitingUntreated Advanced or Recurrent Thymic CarcinomasJapan
-
Novartis PharmaceuticalsCompletedAdvanced Gastric CancerJapan
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerUnited States, Australia, Canada, Japan
-
NovartisCompletedCutaneous T-Cell Lymphoma | TumorsJapan
-
PfizerTerminatedGastric Cancer | Non Small Cell Lung Cancer | Advanced Solid Tumors | Gastroesophageal Junction Cancer | Urothelial Cancer | Head and Neck Squamous Cell CarcinomasUnited States, Japan
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanCompleted